Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Precision Biosciences Inc
(NQ:
DTIL
)
9.950
-0.010 (-0.10%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Precision Biosciences Inc
< Previous
1
2
3
4
5
6
7
8
Next >
Precision BioSciences Hosts Virtual R&D Day Highlighting its Proprietary ARCUS Technology and Recent In Vivo Gene Editing Program Developments
September 12, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Attend and Present at Upcoming September Investor Conferences
September 06, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Host In Vivo Gene Editing R&D Day on September 12, 2023
August 31, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
What Is Precision BioSciences CAR T Pipeline Value? Analyst Lowers Price Target To Justify Valuation
August 17, 2023
Wednesday, Precision BioSciences Inc (NASDAQ: DTIL) announced the completion of a strategic transaction with Imugene Limited for global rights to Azercabtagene Zapreleucel (azer-cel), Precision's lead...
Via
Benzinga
The Latest Analyst Ratings for Precision BioSciences
August 17, 2023
Via
Benzinga
A Preview Of Precision BioSciences's Earnings
August 03, 2023
Via
Benzinga
Preview: Precision BioSciences's Earnings
May 08, 2023
Via
Benzinga
Why Is Precision BioSciences Stock Soaring Today?
August 16, 2023
Precision BioSciences Inc (NASDAQ: DTIL) announced the completion of a strategic transaction with Imugene Limited for global rights to Azercabtagene Zapreleucel (azer-cel), Precision's lead allogeneic...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 16, 2023
Via
Benzinga
Why DLocal Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket
August 16, 2023
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
August 16, 2023
Investors will want to get ready for another busy day of trading as we cover the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
Precision BioSciences Completes Strategic Transaction with Imugene for Azer-Cel in Cancer
August 15, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Reports Second Quarter 2023 Financial Results and Provides Business Update
August 04, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Report Second Quarter Results on August 4, 2023
August 01, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Provides Updates on Azer-Cel FDA Meeting, Potential Partnerships and Timing of In Vivo R&D Day
July 27, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Earnings Scheduled For August 4, 2023
August 04, 2023
Companies Reporting Before The Bell • WPP (NYSE:WPP) is projected to report earnings for its first quarter. • Anglogold Ashanti (NYSE:AU) is likely to report earnings for its first quarter.
Via
Benzinga
3 Penny Stocks to Catapult You Into the Millionaires’ Club
July 13, 2023
These penny stocks can deliver tremendous upside from their depressed range. Wall Street analysts can back it up!
Via
InvestorPlace
Precision BioSciences Announces Oral Presentation of Positive ARCUS® Gene Editing Data at International Liver Congress 2023
June 22, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Wednesday
June 14, 2023
On Wednesday, 33 stocks hit new 52-week lows.
Via
Benzinga
Precision BioSciences to Present at Upcoming June Investor Conferences
June 05, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Provides Update on Allogeneic CAR T Programs and Regulatory Path Forward
May 31, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Provide an Update on its Allogeneic CAR T Programs via Hosted Virtual Webcast and Conference Call on May 31, 2023
May 25, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Participate in Upcoming Stifel Genetic Medicines Day
May 24, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Presents Preclinical Data Demonstrating Potential of ARCUS for Treatment of Duchenne Muscular Dystrophy at the American Society of Gene & Cell Therapy 26th Annual Meeting
May 19, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Announces Publication of its Preclinical In Vivo Gene Editing Abstract on Duchenne Muscular Dystrophy Program for the American Society of Gene & Cell Therapy 26th Annual Meeting
May 12, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Reports First Quarter 2023 Financial Results and Provides Business Update
May 09, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
May 08, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Report First Quarter 2023 Results on May 9, 2023
May 02, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Present Preclinical In Vivo Gene Editing Research for its ARCUS HBV Program at Upcoming Global Hepatitis Summit 2023
April 20, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Announces Late-Breaking Abstract of Preclinical In Vivo Gene Editing Research Selected for Oral Presentation at the American Society of Gene & Cell Therapy 26th Annual Meeting
April 19, 2023
From
Precision BioSciences, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.